Alios BioPharma develops novel antiviral therapies for the treatment of oncology and respiratory diseases... Read more
Alios BioPharma develops novel antiviral therapies for the treatment of oncology and respiratory diseases... Read more
Founder & CEO
Lawrence Blatt
News
Oct 16, 2018
4-traders
Alios Biopharma: Johnson & Johnson : J&J Posts Impairment Charge on Key Drug From Alios Deal
Jul 26, 2017
BioPortfolio
Alios Biopharma: Alios BioPharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile. Report Updated 20072017 Prices from USD $250
Mar 25, 2017
BioPortfolio
Alios Biopharma: Alios BioPharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 22022017 Prices from USD $250
Mar 21, 2017
BioPortfolio
Alios Biopharma: Alios BioPharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 10032017 Prices from USD $250
Mar 08, 2017
Press Release Rocket
Press Release: Alios Biopharma : New Age Music Veterans FIONA JOY and LAWRENCE BLATT - Members of the Group FLOW - Receive Key 2016 ZMR Award Nominations
Jan 20, 2017
BioPortfolio
Alios Biopharma: Alios BioPharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Nov 26, 2016
BioPortfolio
Alios Biopharma: Alios BioPharma Inc. Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Dec 21, 2015
Business Wire
Press Release: Alios Biopharma : Medivir announces that development of the HCV nucleotide polymerase inhibitor AL-704 was terminated by Janssen
Nov 19, 2015
PRESS RELEASE POINT
Press Release: Alios Biopharma : New data published in the New England Journal of Medicine shows potential of compound to fight RSV infection in adults and children
Nov 19, 2015
PHARMIWEB
Alios Biopharma: New Data Published in the New England Journal of Medicine Shows Potential of Compound to Fight RSV Infection in Adults and Children
Alios Biopharma Competitors
1
2
3
4
5
6
7
8
9
10